Corticosteroid-SparingEffectofIntravenousImmunoglobulinTherapyinPatientsWithPemphigusVulgarisNaveedSami,MD;AnsaQureshi,MD;Ele..
内容提示: Corticosteroid-Sparing Effectof Intravenous Immunoglobulin Therapyin Patients With Pemphigus VulgarisNaveed Sami, MD; Ansa Qureshi, MD; Eleonora Ruocco, MD; A. Razzaque Ahmed, MD, DMScBackground: Pemphigus vulgaris (PV) is a rare, poten-tially fatal autoimmune mucocutaneous blistering dis...
Successful Corticosteroid-Sparing Effect of Rituximab in the Treatment of Refractory Idiopathic Orbital Inflammatory DiseaseRituximabIdiopathic orbital inflammatory diseaseIdiopathic orbital inflammatory disease (IOID) is an idiopathic inflammatory process within the orbit that can result in permanent visual ...
To demonstrate the corticosteroid-sparing effect of intravenous immunoglobulin (IVIg) therapy in patients with moderate to severe PV. A retrospective analysis in a cohort of 15 patients with moderate to severe PV who were treated with IVIg therapy. All 15 patients were corticosteroid dependent, and ...
Other benefits of IVIg therapy are that (1) it also has a corticosteroid-sparing effect; (2) it can be used as monotherapy; (3) it is relatively safe compared with systemic corticosteroid therapy; and (4) in addition to controlling PV, it can induce a sustained clinical remission. Further...
1172 Briefcommunications skin, In the four previously reported cases of this associ- ation, PRY preceded Sweet's syndrome; in our patient it was possible to makea retrospective diagnosis ofPRY of 2 years' duration, The male predominance (four of five cases, including our patient) issimilarto...
Subarachnoid neurocysticercosis (SUBNCC) is usually caused by an aberrant proliferative form of Taenia solium causing mass effect and arachnoiditis. Thirty of 34 SUBNCC patients were treated with extended cysticidal and anti-inflammatory... TE Nash,EM O'Connell,DA Hammoud,... - 《American Journal...
Although the corticosteroid-sparing effect of anti-sarcoidosis drugs has been evaluated in previous trials, [7] this has never been used as a primary study endpoint. For such studies to yield meaningful results, they must be carefully designed to account for the natural history of sarcoidosis. Sp...
In this study, we aimed to assess the corticosteroid-sparing effect of tacrolimus in the initial treatment of PM/DM.Yokoyama, YusukeFuruta, ShunsukeIkeda, KeiHirose, KoichiNakajima, HiroshiModern rheumatologyYokoyama Y, Furuta S, Ikeda K, et al. Corticosteroid- sparing effect of tacrolimus in the...
P932 Corticosteroid-sparing effect of mirikizumab for the treatment of moderately-to-severely active Ulcerative Colitis: Extended induction subgroup analysis from Phase 3 trialdoi:10.1093/ecco-jcc/jjad212.1062BACKGROUND. Mirikizumab, an anti-IL-23p19 antibody, has demonstrated efficacy and safety ...